Literature DB >> 9740006

Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization.

P Quellec1, R Gref, L Perrin, E Dellacherie, F Sommer, J M Verbavatz, M J Alonso.   

Abstract

The development of injectable nanoparticulate "stealth" carriers for protein delivery is a major challenge. We have shown the possibility of entrapping human serum albumin (HSA) in polyethylene glycol (PEG)-coated monodisperse biodegradable nanospheres with a mean diameter of about 200 nm, prepared from amphiphilic diblock PEG-polylactic acid (PLA) copolymers, with loadings up to 9% (w/w). Microscopic techniques and surface analysis studies enabled us to prove that the protein was well entrapped and not adsorbed onto the particle surface. Zeta potential and water uptake studies corroborated that part of the PEG chains are located in the nanosphere matrix. Water uptake in the nanospheres was related to their chemical composition, i.e., the respective wt% of PEG and PLA in the matrix, and not on their fabrication procedure. The hydrophilic PEG blocks absorbed up to 130% (w/w) water, whereas PLA absorbed only about 10% (w/w). However, the rate of swelling at the beginning of the process was related to the structure of the matrix, more particularly to the manner in which PEG was disposed at the surface. Furthermore, it was shown that the PEG "brush" at the nanosphere surface drastically reduces HSA adsorption on the PEG-PLA nanospheres compared to the PLA ones.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740006     DOI: 10.1002/(sici)1097-4636(199810)42:1<45::aid-jbm7>3.0.co;2-o

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  20 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

2.  Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density.

Authors:  V C Mosqueira; P Legrand; J L Morgat; M Vert; E Mysiakine; R Gref; J P Devissaguet; G Barratt
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

3.  Synthesis of pegylated immunonanoparticles.

Authors:  Jean-Christophe Olivier; Ramon Huertas; Hwa Jeong Lee; Frederic Calon; William M Pardridge
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

4.  Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability.

Authors:  Claudia Giannavola; Claudio Bucolo; Adriana Maltese; Donatella Paolino; Maria Angela Vandelli; Giovanni Puglisi; Vinecent H L Lee; Massimo Fresta
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

5.  Polyester-poly(ethylene glycol) nanoparticles loaded with the pure antiestrogen RU 58668: physicochemical and opsonization properties.

Authors:  Thibault Ameller; Véronique Marsaud; Philippe Legrand; Ruxandra Gref; Gillian Barratt; Jack-Michel Renoir
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

6.  PEG-grafted chitosan nanoparticles as an injectable carrier for sustained protein release.

Authors:  X G Zhang; D Y Teng; Z M Wu; X Wang; Z Wang; D M Yu; C X Li
Journal:  J Mater Sci Mater Med       Date:  2008-07-15       Impact factor: 3.896

7.  Novel polyester-polysaccharide nanoparticles.

Authors:  Caroline Lemarchand; Patrick Couvreur; Madeleine Besnard; Dominique Costantini; Ruxandra Gref
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

8.  Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI.

Authors:  Amber L Doiron; Kevin Chu; Adeel Ali; Lisa Brannon-Peppas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

9.  Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents.

Authors:  Amber L Doiron; Kimberly A Homan; Stanislav Emelianov; Lisa Brannon-Peppas
Journal:  Pharm Res       Date:  2008-11-26       Impact factor: 4.200

10.  Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice.

Authors:  Vanessa C F Mosqueira; Philippe M Loiseau; Christian Bories; Philippe Legrand; Jean-Philippe Devissaguet; Gillian Barratt
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.